It's never fun when Wall Street analysts change their minds, especially when they're changing them in the wrong direction. Monday brought a fresh batch of downgrades hitting some notable names, with streaming giant Netflix leading the parade of caution.

Here are the five stocks analysts are backing away from this week:

Netflix Loses Its Luster

Rosenblatt analyst Barton Crockett downgraded Netflix Inc. (NFLX) from Buy to Neutral, and that wasn't even the painful part. The price target got chopped from $152 all the way down to $105, a significant haircut for a stock that closed Friday at $100.24. When your price target sits just above where the stock is already trading, that's analyst-speak for "we're no longer expecting much upside here."

Tech and Pharma Feel the Heat

Benchmark analyst Cody Acree downgraded Marvell Technology Inc. (MRVL) from Buy to Hold. The semiconductor company's shares closed at $98.91 on Friday, and apparently that's about where Acree thinks they belong for now.

Meanwhile, Argus Research analyst John Eade moved Novo Nordisk A/S (NVO) from Buy to Hold. The Danish pharmaceutical giant, which has been riding high on weight-loss drug enthusiasm, saw its shares close at $47.86 on Friday. The Hold rating suggests analysts are taking a wait-and-see approach after a strong run.

Energy and Industrials Under Pressure

JP Morgan analyst Arun Jayaram took an even more bearish stance on Occidental Petroleum Corp (OXY), downgrading the energy company from Neutral to Underweight while slashing the price target from $51 to $44. That's particularly noteworthy given the stock closed Friday at $42.43, meaning even the reduced target represents modest upside at best.

Rounding out the downgrade parade, Deutsche Bank analyst Nicole Deblase moved 3M Co (MMM) from Buy to Hold and trimmed the price target from $199 to $178. With shares closing at $167.48 on Friday, there's still some implied upside in that target, but not enough for Deutsche Bank to maintain its Buy rating.

What It All Means

These downgrades span diverse sectors from streaming entertainment to semiconductors, pharmaceuticals, energy, and industrial conglomerates. That broad-based caution might signal analysts are recalibrating expectations across the market, whether due to valuation concerns, changing business fundamentals, or macroeconomic uncertainty. When analysts move from Buy to Hold, they're essentially saying the easy money has been made and it's time to reassess.